Search Browse Earnings

Xenetic Biosciences, Inc. — SlamSEC

Xenetic Biosciences, Inc.

Nasdaq:XBIO

Pharmaceutical Preparations·FRAMINGHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.5M

+48.8% YoY

FY 2024

Adj. EBITDA

-$4.4M

-174.3% margin

FY 2024

Net Income

-$4.1M

-162.8% margin

FY 2024

EPS (Diluted)

-$2.71

FY 2024

Stock Price

$2.31

+0.9%

2026-03-09

52W Range

$1.90 – $13.93

P/E Ratio

-0.9x

Market Cap

$5.3M

Cash

$9.0M

FY 2024

Total Debt

$212,813

FY 2013

Net Cash

$8.8M

FY 2013

Enterprise Value

-$3.5M

Debt / EBITDA

2.0x

FY 2024

EV / EBITDA

0.8x

Employees

—